Delivery Order SPE2DB22D2009-SPE2DB25FL8HM

Award Date 3/17/25
Potential Completion Date 3/18/25
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,201.14 firm fixed-price delivery order is for the procurement of 4566758993 ! VEOZAH 45 MG TABLET 30S, with a period of performance through December 19, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle...
This federal contract award, valued at $3,199.70, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award, with ID SPE2DB22D2009|SPE2DB25FL8EB, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,986.71, is a delivery order for "VEOZAH 45 MG TABLET 30S" and has a completion date of March 6, 2025. The contract is a firm fixed-price arrangement with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,253.26 firm fixed-price delivery order is for the supply of VEOZAH 45 MG TABLET 30S, a medical product. The contract has an ultimate completion date of July 5, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,798.72 firm fixed-price delivery order is for the supply of VEOZAH 45 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order contract with a ceiling value of $3,671.97. The contract is issued by the Defense Logistics Agency (DLA) and is not designated with any set-aside requirements, indicating open competition. The contract is for the supply of 4563692658 ! VEOZAH 45 MG TABLET 30S, a pharmaceutical product. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $3,798.72 firm fixed-price delivery order is for the supply of the pharmaceutical product "VEOZAH 45 MG TABLET 30S". The contract has an ultimate completion date of April 15, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566626227 ! VEOZAH 45 MG TABLET 30S and has a ceiling value of $14,524.58. The contract is a Delivery Order with a Firm Fixed Price pricing type and the ultimate completion date is December 6, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,368.54 fixed-price delivery order is for the supply of 4564909888 ! VEOZAH 45 MG TABLET 30S, with a completion date of June 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $7,544.03 for the supply of "VEOZAH 45 MG TABLET 30S", a pharmaceutical product. The contract has an ultimate completion date of April 3, 2025 and is a Firm Fixed Price type. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB25FL8HM
    Delivery Order

This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,087.56, is for the delivery of 4567603253 ! VEOZAH 45 MG TABLET 30S. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 18, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition.

Generated 6/16/25, 10:56 AM